Pulse Biosciences (PLSE) Other Non-Current Assets (2017 - 2025)
Pulse Biosciences' (PLSE) quarterly Other Non-Current Assets came in at $691000.0 in Q4 2025, up 2.07% year-on-year from $677000.0 in Q4 2024, and down 1.99% quarter-over-quarter from $705000.0 in Q3 2025.
Pulse Biosciences (PLSE) Other Non-Current Assets (2017 - 2025) Analysis & Trends
Pulse Biosciences' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $691000.0 for Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 2.07% year-over-year to $691000.0 in Q4 2025; TTM through Dec 2025 was $691000.0, a 2.07% increase from a year earlier, with the FY2025 full-year figure at $691000.0, up 2.07% from the prior year.
- Other Non-Current Assets declined to $691000.0 in Q4 2025 per PLSE's latest filing, from $705000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $714000.0 in Q2 2024 and bottomed at $365000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $365000.0 (2021), against an average of $476650.0.
- Across the five-year window, Other Non-Current Assets sank 35.05% in 2021 and soared 95.62% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $365000.0 in 2021, then changed by 0.0% to $365000.0 in 2022, then changed by 0.0% to $365000.0 in 2023, then surged by 85.48% to $677000.0 in 2024, then rose by 2.07% to $691000.0 in 2025.
- Per Business Quant, the three latest PLSE Other Non-Current Assets figures stand at $691000.0 (Q4 2025), $705000.0 (Q3 2025), and $677000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - | 691,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 691,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Dec 31, 2024 | 677,000.00 |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | 365,000.00 |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 365,000.00 |
| Mar 31, 2023 | 365,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Sep 30, 2022 | 365,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Dec 31, 2021 | 365,000.00 |
| Sep 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 365,000.00 |